These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10247871)

  • 1. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential and actual drug product selection rates in Florida.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 4. Physician and pharmacist attitudes toward medication use.
    Bootman JL; Hurd PD; Gaines JA
    Am J Hosp Pharm; 1982 May; 39(5):818-21. PubMed ID: 7081254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists.
    Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM
    Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' attitudes toward generic drug substitution by pharmacists.
    Brust M; Hawkins CF; Grayson D
    Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician and pharmacist attitudes toward a generic incentive program.
    Colaizzi JL; Barone JA
    N J Med; 1986 Mar; 83(3):153-6. PubMed ID: 3458036
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug product selection and the law.
    Fink JL
    Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances.
    Fass JA; Hardigan PC
    J Manag Care Pharm; 2011; 17(6):430-8. PubMed ID: 21787028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug product selection: the Florida experience revisited.
    Clouse EH; McCormick WC; Angorn RA; Kimberlin CL; Bradham DD
    Am J Public Health; 1985 Mar; 75(3):283-4. PubMed ID: 3976956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
    Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
    J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug product selection: the Florida experience.
    Vuturo GJ; Krischer JP; McCormick WC
    Am J Public Health; 1980 May; 70(5):479-84. PubMed ID: 7377418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding drug product selection legislation.
    Berger BA
    Contemp Pharm Pract; 1981; 4(2):89-93. PubMed ID: 10250914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTC: our model product selection law relies on the pharmacist's expertise.
    Holmes PD
    Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271
    [No Abstract]   [Full Text] [Related]  

  • 16. Physicians' attitudes toward and knowledge about generic drug substitution.
    Friedman D; Jaffe A; Steinhardt S
    N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs.
    Liu Y; Doucette WR; Farris KB; Nayakankuppam D
    Res Social Adm Pharm; 2005 Jun; 1(2):251-69. PubMed ID: 17138477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of bioavailability to the pharmacist.
    Canada AT
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical ideology and product confidence: future pharmacists' attitudes toward generic drug substitution.
    Pelton LE; Smith MC
    Health Mark Q; 1991; 8(3-4):181-92. PubMed ID: 10111968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.